1. DISINHIBITION SYNDROMES BIOPSYCHOSOCIAL PRESDISPOSERS TO ADDICTIVE DISEASE?

2. 30+ YEARS AS AN OBSERVER AND PARTICIPANT EVALUATING CHILDREN AND ADULTS WHO PRESENTED WITH OR DEVELOPED ADDICTIVE DISEASE FINDING COMMON THEMES IN THE HISTORY AND/OR THE SUBSEQUENT COURSE OF ILLNESS NOTING COMMON COMORBIDITIES IN A POPULATION SEEKING HELP

3. BIOPSYCHOSOCIAL FACTORS IN HUMAN BEHAVIOR BIOLOGICAL PSYCHOLOGICAL SOCIOLOGICAL BASIC TEMPERAMENT INHERITED NBS TOXIC EXPOSURES MALNUTRITION CNS TRAUMA BASIC TRUST DEVEL STAGE IDENTITY POVERTY VIOLENCE SUBCULTURES

4. COMMON PSYCHIATRIC DISORDERS OFTEN COMORBID WITH ADDICTIVE DISEASE ANXIETY DISORDERS DEPRESSION MANIC DEPRESSIVE ILLNESS PERSONALITY DISORDERS SCHIZOPHRENIA TOURETTE SPECTRUM DISORDER ATTENTION DEFICIT DISORDER

5. DISINHIBITION OR AN INABILITY TO REGULATE ONE OR MORE OF THREE BASIC FUNCTIONS IS PRESENT IN THESE DISORDERS THINKING (COGNITION) FEELING (MOOD) ACTING (BEHAVIOR)

6. THINK FEEL ACT ATTENTION/CONC DELUSIONS HALLUCINATIONS OBSESSIONS MOOD SWINGS PANIC DESPAIR RAGE TICS TANTRUMS OVERACTIVITY COMPULSIONS LEARNING DISAB “SYMPTOMS” OF DISINHIBITION

7. “SYMPTOMS” OF DISINHIBITION OFTEN RESPOND TO PRESCRIBED PSYCHOTROPIC MEDICATIONS THESE “SYMPTOMS” MAY RESPOND TO DRUGS AND/OR ALCOHOL AS WELL

8. PRESCRIPTION MEDS CHOSEN AFTER ASSESSMENT TO TARGET A SPECIFIC SYMPTOM OR CLUSTER OF SYMPTOMS PROGRESS,OR LACK OF IT, IS MONITORED SIDE EFFECTS – BEHAVIORAL, NEUROLOGIC, METABOLIC, OTHER, ARE MONITORED

9. DRUGS AND/OR ETOH SELF PRESCRIBED FOR RELIEF OF NON-SPECIFIC SYMPTOMS DESIRED EFFECT IS SOUGHT IN THE FACE OF RAPID TOLERANCE POTENTIALLY DEVASTATING SIDE EFFECTS ARE IGNORED SOCIAL/LEGAL CONSEQUENCES ACCRUE

10. SELF-MEDICATION CATACLYSM CAFFEINE NICOTINE ETHANOL THC COCAINE OPIATES PAIN PILLS, BENZOS ETC